
ForCast and KORU Partner on New Antibiotic Infusion Therapy
ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. jointly announced an agreement leveraging KORU Medical’s FreedomEDGE infusion system as part of ForCast’s technology platform for
ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. jointly announced an agreement leveraging KORU Medical’s FreedomEDGE infusion system as part of ForCast’s technology platform for
Brain Co., a company backed by Elad Gil, Jared Kushner, Luis Videgaray, and Eric Wu, has officially exited its stealth mode and raised $30 million
INNOVATE Corp. announced that R2 Technologies, Inc. the innovators behind the breakthrough Glacial Skin technology, and an operating subsidiary of INNOVATE, achieved a second-quarter 2025 revenue
Epigenic Therapeutics, a clinical-stage biotech company specializing in epigenetic-based drug development, has secured $60 million in a Series B funding round. The round was led
Servier, an independent international pharmaceutical group run by a foundation, has announced a final agreement to buy KER-0193 from Kaerus Bioscience. KER-0193 is a promising
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical trials Atelerix, a biotech company
Meroka has officially launched and raised $6 million in seed funding, led by Better Tomorrow Ventures and Slow Ventures, with additional contributions from 8VC and
LPOXY Therapeutics, Inc., a clinical-stage biopharmaceutical company, is developing a new way to prevent Clostridioides difficile infections (C. diff) that doesn’t rely on antibiotics. The
RBL LLC, a biotech startup studio based in Houston, has announced a new strategic investment from Carnrite Ventures. This funding will help accelerate RBL’s mission
Avista Healthcare Partners (Avista), a private equity firm focused exclusively on healthcare, announced an agreement to participate in PK Benelux, a key player in the
Medical Horizons S.r.l., a well-known distributor of AI-based healthcare solutions, has announced a special agreement with Bowhead Health Inc., a Canadian company that focuses on
MediSpend and RLDatix Life Sciences, a part of RLDatix, have officially announced a deal to merge, creating a new company that will lead in innovation